Pulmonary fibrosis is a lung disease where the air sacs and tissue in the lungs get stiff and scarred. This makes it harder to breathe and perform everyday activities. The ...

Bronchiectasis guidelines are inconsistent with regard to the effectiveness of mucoactive agents, and their use varies ...

A recent study outlines how artificial intelligence advancements are transforming research and therapeutic strategies for idiopathic pulmonary fibrosis.

LTI-03 was shown to reduce inflammation and scarring in lung tissue collected from IPF patients and analyzed in a lab, ...

Patients with acute exacerbations of idiopathic pulmonary fibrosis (IPF) or progressive pulmonary fibrosis (PPF) face a high risk of morbidity and mortality and require careful, expert management, ...

For a long time, physicians and scientists believed our lungs were sterile (germ-free). But modern science indicates ...

Researchers at the University of Calgary studying a lethal lung disease called pulmonary fibrosis have found that neurons ...

Researchers at the University of Calgary studying a lethal lung disease called pulmonary fibrosis have found neurons, which were known to help detect pain, are also critical for reducing harmful lung ...

Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on the development of inhaled therapies for the treatment of life-threatening pulmonary diseases, today announced a poster ...

SRPX2 (Sushi Repeat-Containing Protein X-Linked 2) is a multifunctional regulatory protein that has recently been implicated in various pathological conditions. In a recent review published in ...

CLEVELAND, Ohio — Many patients with advanced cystic fibrosis — an illness that causes thick mucus secretions — turn to lung transplants to improve their quality of life. But in taking that step, they ...